← Back to FBLG

FibroBiologics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 31/07/2026Mar 2026Filed 31/07/2026Sep 2025Filed 31/10/2025Jun 2025Filed 31/07/2026Mar 2025Filed 31/07/2026Sep 2024Filed 31/10/2025Jun 2024Filed 31/10/2025Mar 2024Filed 31/10/2025
−$4.1−$5−$5.8−$4.7−$5−$0.5$0.9−$8.5
−$0.66−$1.33−$0.13−$2.41−$2.71−$0.01$0.03−$0.27
6.33.843343331

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.